NFXF Biobank launched in support of Biomarker Research Program

//NFXF Biobank launched in support of Biomarker Research Program
NFXF Biobank launched in support of Biomarker Research Program 2018-01-29T18:14:21+00:00

NFXF Biobank™

NFXF Biobank™ launched in support of Biomarker Research Program

National Fragile X Foundation launches NFXF Biobank™ in support of its NFXF Collaborative Biomarker Research Program, accelerating research into Fragile X treatments and cures.

The National Fragile X Foundation (NFXF) announces the launch of the  NFXF Biobank™, the first major project of the NFXF Collaborative Biomarker Research (CBR) Program. The program is designed to drive faster and more cost-effective research into treatments and eventual cures for the family of Fragile X (FX) disorders.

Read the Official Press Release

Combining Biological Samples with Clinical Information to create NFXF Research Ready Materials™

Select Fragile X Clinics throughout the USA collect and ship the biological samples of volunteer participants from the FX community. The de-identified samples are received, processed, characterized, and stored in the newly formed NFXF Biobank™ at UC Davis MIND. De-identified clinical data from these same participants, in combination with their biological materials, create unique NFXF Research Ready Materials™.

The Benefits of NFXF Research Ready Materials™

Giving access to the NFXF Research Ready Materials™ will allow any FX researcher the ability to accelerate the correlation of behaviors and medical conditions associated with Fragile X to their underlying biology, also known as biomarkers. Identifying these correlations is critical to allow pharmaceutical researchers to target the underlying biological mechanism for treatment or cures.

While the search for useful FX biomarkers has been underway in the FX research community for some time, never before has there been a resource like NFXF CBR Program or the NFXF Biobank™, created to unify, consolidate and make broadly available NFXF Research Ready Materials™ for accelerated biomarker research, and eventually to faster treatments and cures for the Fragile X family of disorders.

Collaborators and Scope of the Program

The initial goal is to have 30 participants at each clinic for a total of 90 participants per year. The NFXF plans to raise money in the short term to expand the program to include more participants and clinics.  This is an incredibly exciting milestone for the entire Fragile X community, and with your financial support we can accelerate the development of effective treatments and a cure for Fragile X.

NFXF Biobank™ Frequently Asked questions

1861 International Drive Suite 200, McLean, VA 22102, (800) 688-8765

Privacy Policy | Powered by PRI

Copyright © 2018 National Fragile X Foundation

en English
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laolv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sudanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu